Search Results

You are looking at 1 - 10 of 3,077 items for :

  • "treatment" x
  • Refine by Access: All x
Clear All
Full access

Eric T. Wong and Steven Brem

: 649 . 5. Mayer RJ . Two steps forward in the treatment of colorectal cancer . New Engl J Med 2004 ; 350 : 2406 – 2408 . 6. Shweiki D Itin A Soffer D . Vascular endothelial growth factor induced by hypoxia may mediate hypoxia

Full access

Harry S. Cooper

1986 ; 91 : 419 – 427 . 8. Bond JH . Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology . Am J Gastroenterol 2000 ; 95

Full access

Lindsey Robert Baden, William Bensinger, Michael Angarone, Corey Casper, Erik R. Dubberke, Alison G. Freifeld, Ramiro Garzon, John N. Greene, John P. Greer, James I. Ito, Judith E. Karp, Daniel R. Kaul, Earl King, Emily Mackler, Kieren A. Marr, Jose G. Montoya, Ashley Morris-Engemann, Peter G. Pappas, Ken Rolston, Brahm Segal, Susan K. Seo, Sankar Swaminathan, Maoko Naganuma, and Dorothy A. Shead

). The major categories of immunologic deficits in persons with cancer and the major pathogens to which they are susceptible are characterized. Specific guidelines are provided on the prevention, diagnosis, and treatment of the major common and

Full access

Aaron P. Mitchell, Sara M. Tabatabai, Pranammya Dey, Jennifer A. Ohn, Michael A. Curry, and Peter B. Bach

drug prices reflect significant improvements in effectiveness is therefore germane to ongoing legislative attempts at drug price reforms. Whether treatment price may reflect clinical benefit across all cancer treatment settings, not only among newly

Full access

Thomas Prebet and Steven D. Gore

T he treatment of acute myeloid leukemia (AML) in older patients remains challenging. 1 Both disease- and patient-related factors unfavorably influence patient outcome, with a 2-year probability of overall survival of 10% to 15%. 2 Acute

Full access

Areej El-Jawahri, Deborah Forst, Alyssa Fenech, Keri O. Brenner, Amanda L. Jankowski, Lauren Waldman, Isabella Sereno, Ryan Nipp, Joseph A. Greer, Lara Traeger, Vicki Jackson, and Jennifer Temel

Background Patients with advanced cancer require a clear understanding of their treatment goals and prognosis to make informed decisions about their medical care. 1 – 5 Yet multiple studies have shown that patients with advanced cancer often have

Full access

R. Lor Randall and William Gowski

. Instr Course Lect 1996 ; 45 : 417 – 424 . 4 Marcove RC Stovell PB Huvos AG . The use of cryosurgery in the treatment of low and medium grade chondrosarcoma. A preliminary report . Clin Orthop 1977 ; 122 : 147 – 156 . 5 Reith

Full access

Saurabh Rajguru and Brad S. Kahl

/print certificate. Release date: September 5, 2014; Expiration date: September 5, 2015 Learning Objectives Upon completion of this activity, participants will be able to: Summarize the current and emerging treatment options for MCL in the frontline

Full access

Alejandro Garcia-Horton and Jeffrey H. Lipton

possible without widespread treatment and availability of TKIs, resulting in disease control and molecular response. Treatment-free remission (TFR) has emerged as a new goal for many patients with CML as a distinct outcome other than overall survival (OS

Full access

Xiang Gao, Amanda R. Kahl, Paolo Goffredo, Albert Y. Lin, Praveen Vikas, Imran Hassan, and Mary E. Charlton

combination of treatments available to patients with metastatic colon cancer, the objective of this study was to use data from the SEER POC study to examine the patient, tumor, and hospital factors associated with each of the following treatment categories: (1